Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Phase 4
Recruiting
- Conditions
- Pulmonary EmbolismEmbolismEmbolism and ThrombosisLung DiseasesRespiratory Tract DiseasesVenous ThromboembolismBleedingCardiovascular DiseasesAnticoagulant-induced Bleeding
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- Drahomir Aujesky
- Target Recruit Count
- 276
- Registration Number
- NCT04263038
- Locations
- 🇧🇪
Centre hospitalier universitaire de Liege, Liège, Belgium
🇧🇪Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe, Belgium
🇨🇦The Ottawa Hospital, Ottawa, Canada
News
No news found